| 摘要 |
The invention relates to a method for producing a solid, orally applicable pharmaceutical composition containing 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophen carboxamide in a hydrophilized form, and the use thereof for preventing and/or treating diseases. |
